Published in Women's Health Law Weekly, November 27th, 2005
Scientists in the United States conducted research "to establish a laboratory animal model for vascular endothelial growth factor (VEGF) transfer in the rat penis to invent a curative therapy for ED. Vascular insufficiency is a common pathomechanism of ED."
"Previous investigations have shown neovascularization of ischemic organs after gene transfer of VEGF. For VEGF-protein transfer, osmotic pumps were connected to the renal arteries of rats. The pumps were filled with human VEGF165 protein (n=20) or sterile saline (n=20). After 28 days, a VEGF serum...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Law Weekly